All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Noxxon Pharma NV, of Berlin, said an unnamed top 10 international pharmaceutical company has signed an agreement with Noxxon for the purpose of evaluating NOX-A12 (olaptesed pegol) in a new indication, which will remain undisclosed for competitive reasons.